Zhang G - Search Results

1

Presence of circulating tumor cells is associated with metabolic-related variables in postoperative patients with early-stage breast cancer.

Shi Y, Zhang G, Wang Y, Ren C, Wen L, Zhu W, Chen X, Liao N. Shi Y, et al. Among authors: zhang g. Chin J Cancer Res. 2018 Jun;30(3):340-350. doi: 10.21147/j.issn.1000-9604.2018.03.06. Chin J Cancer Res. 2018. PMID: 30046228 Free PMC article.

2

[A meta-analysis of neoadjuvant chemotherapy combined with trastuzumab for HER2-positive breast cancers].

Liao N, Zhang GC, Li XR, Yao M, Wang K. Liao N, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2009 May;29(5):943-5. Nan Fang Yi Ke Da Xue Xue Bao. 2009. PMID: 19460715 Chinese.

3

Efficacy of intraoperative GeneSearch Breast Lymph Node (BLN) Assay for breast cancer metastasis detection in sentinel lymph node in Chinese patients.

Liu YH, Xu FP, Liao N, Li L, Zhang GC, Zhuang HG, Mei P, Xu J, Zhu XL, Luo XL, Kuang LJ. Liu YH, et al. Cancer Sci. 2010 Aug;101(8):1920-4. doi: 10.1111/j.1349-7006.2010.01618.x. Epub 2010 Jan 17. Cancer Sci. 2010. PMID: 20557308 Free PMC article. Clinical Trial.

4

[Efficacy and safety assessment of neoadjuvant paclitaxel and trastuzumab in Chinese women with Her-2 positive operable breast cancer].

Liao N, Zhang GC, Li XR, Yao M, Wang K, Zu J. Liao N, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):544-7. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029701 Clinical Trial. Chinese.

5

HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component.

Liao N, Zhang GC, Liu YH, Li XR, Yao M, Xu FP, Li L, Wu YL. Liao N, et al. Pathol Res Pract. 2011 Jan 15;207(1):1-7. doi: 10.1016/j.prp.2010.08.005. Epub 2010 Nov 20. Pathol Res Pract. 2011. PMID: 21095069

6

Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients.

Zhang GC, Qian XK, Guo ZB, Ren CY, Yao M, Li XR, Wang K, Zu J, Liao N. Zhang GC, et al. Med Oncol. 2012 Dec;29(5):3222-31. doi: 10.1007/s12032-012-0242-8. Epub 2012 May 1. Med Oncol. 2012. PMID: 22547076

7

Accuracy and axilla sparing potentials of sentinel lymph node biopsy with methylene blue alone performed before versus after neoadjuvant chemotherapy in breast cancer: a single institution experience.

Zhang GC, Liao N, Guo ZB, Qian XK, Ren CY, Yao M, Li XR, Wang K, Zu J. Zhang GC, et al. Clin Transl Oncol. 2013 Jan;15(1):79-84. doi: 10.1007/s12094-012-0885-0. Epub 2012 Aug 28. Clin Transl Oncol. 2013. PMID: 22926944

8

Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy.

Wang K, Deng QT, Liao N, Zhang GC, Liu YH, Xu FP, Zu J, Li XR, Wu YL. Wang K, et al. Tumour Biol. 2013 Feb;34(1):33-8. doi: 10.1007/s13277-012-0507-z. Epub 2012 Sep 14. Tumour Biol. 2013. PMID: 22976542

9

[Implantation metastasis of breast cancer in vacuum-assisted breast biopsy needle tract and the impact of neoadjuvant chemotherapy].

Ren C, Liao N, Zhang G, An S, Wen L, Qian X, Lü H. Ren C, et al. Among authors: zhang g. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jun;34(7):1016-9, 1024. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 25057075 Chinese.

10

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer.

Chen B, Tang H, Chen X, Zhang G, Wang Y, Xie X, Liao N. Chen B, et al. Among authors: zhang g. Cancer Manag Res. 2018 Dec 21;11:179-190. doi: 10.2147/CMAR.S187151. eCollection 2019. Cancer Manag Res. 2018. PMID: 30613165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,385 results

Search Page

Filters